Tag Archives: Good business

What makes Havas Lynx special?

The #LXAcademy, by David Hunt

“What is your point of difference?”, “Why should I work with you?”, or my personal favourite, “What makes Havas Lynx so special?” The answer is always the same – the people. But “people” does not just happen by chance. It takes investment, it takes values & it takes culture.

On the 30th of April we launched #LXAcademy 2015 at Manchester Town Hall. It was an awesome event, which reflected our commitment to, and investment in, skills development. Lucy May was inspiring as she discussed the opportunities for progressive change in healthcare with a commitment to a more holistic patient journey, fuelled by creativity. Dave Birss then followed with some phenomenal case studies that were deconstructed to their core, as we explored the discipline behind creativity. Dave beautifully illustrated the power of ideas to drive change across society. However, the greatest point of inspiration was the collective passion & expertise of the Havas Lynx community, with over two-hundred experts committed to Helpful Change in healthcare.

Over the next six months there will be over one-hundred sessions, covering Agency Fundamentals, through to Core Expertise and Thought Leadership. Not everyone in an agency has an eye for design, not everyone can use PowerPoint, and not everyone has a quality first approach – they should. The curriculum for Agency Fundamentals seeks to change this. Numerous articles and research papers discuss the most likely reason an agency would be sacked, and it’s almost always a lack of quality, attention to detail, or put another way – the fundamentals. The details count, and they are a priority for Havas Lynx.

I’d like to be a better CEO, and I’m sure that I am not alone in wanting to be better at the day job. We’ll be tackling payors and market access, content designed for a more social world, and the account teams will spend time with a restaurant manager to discuss silver service. It’s amazing the amount agencies spend on recruitment and salaries, and then neglect training and development.

The Thought Leadership programme will include discussing teamwork and marginal gains in a Formula One pit-lane, how an NHS Trust uses twitter to manage patient well-being and how the police negotiate with terrorists. All of the sessions are made available on YouTube, with last year’s #LXAcademy attracting 100,000 views, to further validate the quality.

Like all things the success of the #LXAcademy 2015 will be based on the people, the more they put in the more they will get out. As always, I’m happy backing the Havas Lynx community.

Good Cause

Doing Good, While Making Money

Social Success, by David Hunt

I talk about this a lot, but make no apologies for the frequency. I’m proud to work in Pharma, and see it as an opportunity to use insight, imagination & innovation to make a difference. I didn’t choose to work in healthcare, I simply liked ideas. In all honesty, as a bullish graduate I would have preferred Nike over Pfizer, but the world changes, and so do we. Today I choose to have a significant impact on society, over a cool one.

Paul Polman, CEO of Unilever, says: The business benefits from ethical practices are not soft ones about reputation or image. They are hard measures of growth and margin improvement. Wherever you look, it’s a no-brainer.

I agree 100%. Havas Lynx aims to help patients, their families and HCPs to improve outcomes, whilst also driving the commercial success of our clients. We call it #HelpfulChange, and whilst it sounds improbable and unrealistic, it has been the central strategy behind our success. It aligns with the increasing trend for Pharma companies to out behave the competition & benefit through their enhanced brand equity. Unfortunately the more conservative in our industry wait for others to fail & win by default. Doing nothing, but doing nothing wrong, they would argue. These people fear their brand, and lack the courage their power affords them to improve society. Those that embrace this power, those that choose to make a difference, and show courage in their actions, will succeed in today & tomorrow’s social world – they’ll have a brand with meaning.

Johnson & Johnson have invested in Care4Today, through Janssen Healthcare Innovations. Like many others, they believe innovation can improve outcomes. However, unlike the majority, they have invested significant time & resource to bring forward that day. They will both make a difference, and secure a competitive advantage.

AstraZeneca invested in a critical testing infrastructure for non-small cell lung cancer. Monthly tests increased from 18 to 452 over the course of the campaign. Patients were more accurately diagnosed, treatments more accurately prescribed.

Novartis support Skin To Live In and, despite the regulatory challenges, aspire for it to be the most progressive campaign in healthcare communications, supporting the community & building brand equity – a fair trade.

These are just a few examples from our portfolio, beyond Havas Lynx there are numerous other superb cases of brands doing good and making money. It is the future of our industry, one that will be shaped by passion & courage.

Hand shake croped

Our Impact in 2014

Agency Management, by David Hunt

2014, great clients, great work, great team – a great year. They’ll always be lows, but not often are they so outnumbered by the highs.

Creative Lynx was founded in 1986, shortly after a design graduate joined, today he is a Managing Partner. In 2000 the agency sponsored a Product Design undergraduate, today he is the CEO. HAVAS LYNX have a heritage of investing in bright, passionate, ambitious talent, and 2014 was no different. Over twenty graduates joined the team this year, bringing a freshness to our thinking and contemporary ideas to our strategies.

Not so long ago our business was national, and whilst we still very much enjoy the challenges
that the local market represents, today the majority is global. It ensures our ideas have a more significant impact, that we can make a bigger difference & do more. But it also ensures that we support our local economies, generating significant inward investment to London & Manchester. In addition, we created an additional thirty jobs, or one job every two weeks.

Roller Coaster - blog

 

 

 

 

 

 

 

 

I’ve talked a lot about #LXAcademy, it reflects the pride I take in our achievement and the excitement for the 2015 curriculum. The #LXAcademy is not about new business, driving commercial success, or making money. It is a recognition that for all the big ideas & business strategies, we are only as good as our people. And the #LXAcademy ensures that ours remain the best.

In the last two years HAVAS LYNX have raised over £60k with a social reach of 200k for the causes we champion, and in the two weeks before Christmas we sponsored a year’s education for 42 children in Africa. It’s humbling to realise that the team’s passion to make a difference doesn’t start & stop with client budgets #HelpfulChange

The death of traditional consumerism: what does it mean for pharma?

HAVAS Worldwide’s latest paper, The New Consumer & The Sharing Economy, outlines a growing sentiment against over consumption. Seven in ten of us believe it to be putting our society and the planet at risk, and the majority feel that current models of consumerism are not sustainable. More than this, we feel weighed down by the sheer amount of ‘stuff’ we own.

72983288

Put simply, we’re tired of consumerism and bored of adverts that try to manipulate us by pushing products at us like they’re the answer to life’s problems. We want to be in control, we want to be able to make informed decisions about how we spend our time and money and we don’t want others telling us what to do.

This goes for healthcare as much as consumer markets. Patients no longer expect to merely be prescribed a pill that they unwittingly swallow down once a day and hope for the best. Facilitated by an abundance of information technologies, they are knowledgeable about treatments and want to be actively involved in managing their own health care.

The wealth of monitoring apps across treatment areas (AsthmaCheck, MoodPanda and Diabetes In Check are but a few) is a fair indicator of a general desire for information and authority regarding personal treatment regimens. For financially hamstrung public health providers such as the NHS, this is a welcome trend. Empowering patients with greater control of their treatment reduces the burden of care placed on public providers, and has the potential to garner much better results by actively engaging patients.

So where does pharma fit into all this? The patent model and subsequent relationship with healthcare providers has always followed traditional models of consumerism; ‘we are a drug company and we’ve produced this drug which you can buy from us’. So how can we who work in pharma support and facilitate patients’ desires for greater inclusion and authority in their care and still turn a profit?

Firstly, we need to reshape our relationship with the people we serve. Pharmaceutical companies can no longer act as vendors and must become partners to professionals and patients alike. In doing so, we need to provide solutions, not pills, and increasingly this will mean delivering holistic services and systems of care. ‘Beyond the pill’ solutions are an arena in which there is massive potential for pharmaceutical companies to add real value.  At HAVAS LYNX we’ve worked on a series of patient care programmes that have been shown to half the number of days patients spend in hospital.

When pharma partners its expertise with other parties, it opens up a world of new revenue streams. Start-up accelerator organisations such as Healthbox are stimulating the sort of innovation and collaboration that pharma should be looking to more and more. Even amidst the context of Pfizer’s efforts to secure the acquisition of AstraZeneca, pharma companies need to look beyond traditional development pipelines when seeking to expand their offering.

We need to innovate past the sector mainstream and recognise outsider trends, much in the same way that Facebook is making moves to expand beyond social by purchasing of ProtoGeo. There are so many exciting and disruptive technologies being developed that have the potential to transform the lives of patients. Far more than offering supplementary revenue, these areas that currently lie on the fringes of the market are likely to be the mainstay of pharmaceuticals in the future.

 

HAVAS LYNX Named Havas Agency of the Year

Network life, by David Hunt

We joined the Havas network on the 31st May 2012. On the 22nd of January 2014 we were named Havas Agency of the year. This accolade is our single greatest award. Representing healthcare in a consumer world, competing with the likes of the brilliant BETC, Cake and One Green Bean, we have proven that pharmaceutical marketing can be just as exciting, just as creative and just as innovative as the B2C world. In fact, we have demonstrated that it can be better.

We joined Havas due to their passion, energy and creativity. They are the group behindEvian’s Roller Babies campaign (77 million views on YouTube) and the Baby & Me campaign (71 million views on YouTube). More recently, the team in Australia launched the Doug Pitt campaign and from Paris BETC launched ‘The Bear’ for Canal+.

Healthcare can often be seen as the ugly duckling of advertisement; stifling creativity in favour of science. I would argue that it simply raises the bar of the creative expertise required to succeed within the sector. I am not diminishing the talent required to make Aldi exciting, but it requires a different expertise, determination and creative confidence to succeed in healthcare communications.

There is a belief in media and communications that global networks buy all of the best talent and break them. There are a number of cases and stories within the industry of once amazing agencies losing their sparkle, independence and passion. This fear was echoed by a number of our clients when we announced our deal with Havas. Had our deal been purely based on financials we would have chosen a different partner. Had we not wanted to evolve the agency, and been happy to rest on our laurels, we would not have found a partner at all. As a senior team, we recognised the need to develop our offering, enhancing our global presence and bolstering our strategic offering, to complement our natural creativity and innovation. This award is a testament to Havas: making us stronger, not weaker; our service more agile, less bloated; our campaigns smarter, less fanciful.

Plane

It would be wrong to say that 2013 was easy. It was not. It was incredibly hard. In the first 6 months we had a number of tough projects, internal challenges and inevitable growing pains. The fact we turned things around and closed 2013 so strongly demonstrates the strength of character that runs from the bottom to the top of our agency, from strategy to delivery, from reception to board. It also fills us all with real confidence for 2014, as we look to build upon robust client partnerships, a responsive structure and exceptional people.

What next? HAVAS LYNX will continue to demonstrate that creativity and innovation in healthcare communications is defined by passion and ideas, not legislation and fear.

10, 20, 50, 100 or 1,000; what’s the perfect size for an agency?

Client / Agency relationships, by David Hunt

178, the size of HAVAS LYNX. Ask anyone that manages an agency of 178 & they will say the same – it’s perfect. I imagine that in a few weeks 181 will be even more perfect. 

For years we were perceived as being too small. Now we are too big to be innovative, yet still too small to be a player?!? I disagree with both opinions.

Innovation & creativity is not about headcount. Never has been, never will be. It’s about people, passion & culture. With a background in digital, technology & creativity, I was appointed CEO at the age of 33. I’m driven by ideas & not numbers. Supported by a management team that believes in great work, we  now invest in more diverse expertise, try more unique technologies & chase more ideas than ever before. We are constantly looking for new concepts for ourselves, for our clients, for HCPs & for patients.

Can you be small, commercially motivated & technology agnostic? With the correct approach and the right people, perhaps. However, are you more likely to settle with the specialist you shared lunch with, or the unknown you still need to locate? With a big agency comes diverse expertise under one roof, providing seamless access to broad ideas. But can you be big & still bright? Certainly, but only by breaking down silos & embracing diversity. Different experiences, points of view & interests inspire innovation.

Like the story of Goldilocks, some agencies are too big, some agencies are too small, and some agencies are just right – it depends on your taste.

Three Bears

It is a matter of taste

Another strange question – do you have enough capacity? Does a prospective customer really want an agency that’s quiet? I’ve never walked into an empty restaurant, however if it’s heaving I want a reservation – evidence suggests that the product will be great. Do you want a partner that is free, or do you want a partner that is expert? A well run agency will have the infrastructure, process & connections to scale smartly and meet the fluid needs of their customers.

I’m proud to say that we are very big and we are very busy. And our clients choose HAVAS LYNX for our  ideas, innovation & ability to exceed expectations, and we are grateful for their patronage. 

High5ives to the team at HAVAS LYNX

Good business, by David Hunt

25,302 pounds in just one year, 500 pounds per week for 52 weeks, or 150 pounds per person – however you decide to analyse the efforts and achievements of the HAVAS LYNX #High5ives team this year, it is a tremendous effort. But CSR doesn’t just include charitable donations & raising money, they went much, much further.

£25,302 raised in 2013.

£25,302 raised in 2013.

It was just over twelve months ago when Tim Woodcock, General Manager LYNX London, developed a penchant for 30 mile runs. Further investigation uncovered his proposed participation in Marathon des Sables: The Toughest Footrace on Earth. It was a phenomenal effort; equally phenomenal was the support that Tim would receive from the agency. The endeavour also saw Nick Greenwood create the #High5ives brand, which became a catalyst for our CSR movement. In the age of damage, it perfectly illustrates the impact of a genuine brand, with values, behaviour, and personality entirely aligned.

High5ives Brand

#High5ives

50 pints of blood were donated by members of HAVAS LYNX. Each donation had the ability to save 3 lives. The initiative was led by Julie Southam, who delivered an exceptional service to her clients, whilst simultaneously organising critical help for 141 strangers. As an agency, we believe that who cares wins and in helpful change. Our campaigns are centred on patient wellbeing, so too are many of our personal activities.

Leanne Ledger leads our activities in higher education; she also helped to educate the wider community on the 1.4 billion people that live in extreme poverty. Living on just £1 per day for a week, Leanne raised money & awareness through https://www.livebelowtheline.com. Our social reach is 142,750 in 2013.

James Young ran a marathon dressed as “Where’s Wally”, featured in the MEN, made sandwiches for the office every Thursday, and raised £1,000 for AMREF. The team ran another 300km as part of the BUPA Great Manchester Run, with all proceeds going to Motor Neurone Disease Association. In October Lukeki participated at The One Young World Summit 2013, having won one our internal competition. Following the inspirational event, Lukeki will be launching her initiative to tackle self-esteem issues and the wider problems low self-esteem can bring.

Continuing the #High5ives theme into 2014, HAVAS LYNX Medical will be launching one of the industry’s first events focussed entirely on ETHICS, and asking, “Ethics and the Pharmaceutical Industry: Is compliance enough?” The one-day interactive symposium will explore some of the ethical issues that confront the industry, with all proceeds going to NeuroMuscular Centre. Chaired by Mr Michael Buerk, with confirmed speakers including Dr Des Spence Glasgow GP & BMJ columnist, Mr Gyles Brandreth Raconteur & former Conservative MP and Dr Karl Wilding Director of Public Policy, National Council for Voluntary Organisations.

In keeping with the #High5ives theme and as we concluded 2013, the team decided on local charities over Christmas cards. Throughout December and into January, they are collecting donations for Barnabus, Wood Street Mission and Whitechapel Mission. Great charities that are in even greater demand over the holiday season. It’s a fitting end to a great first year for High5ives. Led by Claire Knapp & Tom Wordley, and supported by Claire Elliot, I have little doubt that this is just the beginning.

As CEO, their energy & achievements fill me with immense pride, equally their passion & expertise fill me with great confidence for the future.